Statistics
Publications
3
Citations
267
H-Index
3
Active since
2003
Affiliations
Kate Byth is an author at AstraZeneca (United Kingdom) specializing in pharmacology, oncology, and medicine.
Publications per year
2003–2012
3
3
Mechanism and <i>In Vitro</i> Pharmacology of TAK1 Inhibition by (5<i>Z</i>)-7-Oxozeaenol
Jiaquan Wu, Francoise Powell, Nicholas Larsen et al. · ACS Chemical Biology · 2012 · 142 citations
Medicine, Oncology, Pharmacology +13
Malcolm Anderson, John F. Beattie, Gloria A. Breault et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 114 citations · Full text
Novel approaches in oncology at AstraZeneca
Catherine Wheeler, T C Stephens, Kate Byth et al. · European Journal of Cancer Supplements · 2003 · 11 citations
Medicine, Oncology, Pharmacology +6
1–3 of 3